Description: Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients with unmet medical needs.
Home Page: www.kintara.com
KTRA Technical Analysis
9920 Pacific Heights Blvd
San Diego,
CA
92121
United States
Phone:
858 350 4364
Officers
| Name | Title |
|---|---|
| Mr. Robert E. Hoffman B.B.A., CPA, CPA | Pres, CEO & Chairman |
| Dr. Dennis M. Brown B.Sc., M.A., Ph.D. | Co-Founder & Chief Scientific Officer |
| Mr. Scott Praill B.Sc., C.P.A., CA, CPA, BSc | CFO & Sec. |
| Mr. Jeffrey A. Bacha B.Sc., M.B.A. | Founder |
| Mr. Greg A. Johnson | Acting Head of Operations |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 7.8075 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2013-02-22 |
| Fiscal Year End: | June |
| Full Time Employees: | 3 |